Literature DB >> 18938222

Allelic mRNA expression of sortilin-1 (SORL1) mRNA in Alzheimer's autopsy brain tissues.

Houda Alachkar1, Maria Kataki, Douglas W Scharre, Audrey Papp, Wolfgang Sadee.   

Abstract

Polymorphisms in the gene encoding SORL1, involved in cellular trafficking of APP, have been implicated in late-onset Alzheimer's disease, by a mechanism thought to affect mRNA expression. To search for regulatory polymorphisms, we have measured allele-specific mRNA expression of SORL1 in human autopsy tissues from the prefrontal cortex of 26 Alzheimer's patients, and 51 controls, using two synonymous marker SNPs (rs3824968 in exon 34 (11 heterozygous AD subjects and 16 controls), and rs12364988 in exon 6 (8 heterozygous AD subjects)). Significant allelic expression imbalance (AEI), indicative of the presence of cis-acting regulatory factors, was detected in a single control subject, while allelic ratios were near unity for all other subjects. We genotyped 7 SNPs in two haplotype blocks that had previously been implicated in Alzheimer's disease. Since each of these SNPs was heterozygous in several subjects lacking AEI, this study fails to support a regulatory role for SORL1 polymorphisms in mRNA expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18938222      PMCID: PMC2612539          DOI: 10.1016/j.neulet.2008.10.034

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  18 in total

1.  Single nucleotide polymorphism genotyping using allele-specific PCR and fluorescence melting curves.

Authors:  Audrey C Papp; Julia K Pinsonneault; Glen Cooke; Wolfgang Sadée
Journal:  Biotechniques       Date:  2003-05       Impact factor: 1.993

Review 2.  Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics.

Authors:  Andrew D Johnson; Danxin Wang; Wolfgang Sadee
Journal:  Pharmacol Ther       Date:  2004-12-15       Impact factor: 12.310

3.  Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

Authors:  Ying Zhang; Danxin Wang; Andrew D Johnson; Audrey C Papp; Wolfgang Sadée
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

4.  Allelic mRNA expression of X-linked monoamine oxidase a (MAOA) in human brain: dissection of epigenetic and genetic factors.

Authors:  Julia K Pinsonneault; Audrey C Papp; Wolfgang Sadée
Journal:  Hum Mol Genet       Date:  2006-08-07       Impact factor: 6.150

5.  Allelic expression of serotonin transporter (SERT) mRNA in human pons: lack of correlation with the polymorphism SERTLPR.

Authors:  J-E Lim; A Papp; J Pinsonneault; W Sadée; D Saffen
Journal:  Mol Psychiatry       Date:  2006-01-24       Impact factor: 15.992

6.  SORL1 haplotypes modulate risk of Alzheimer's disease in Chinese.

Authors:  E K Tan; J Lee; C P Chen; Y Y Teo; Y Zhao; W L Lee
Journal:  Neurobiol Aging       Date:  2007-12-11       Impact factor: 4.673

7.  Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability.

Authors:  Danxin Wang; Andrew D Johnson; Audrey C Papp; Deanna L Kroetz; Wolfgang Sadée
Journal:  Pharmacogenet Genomics       Date:  2005-10       Impact factor: 2.089

Review 8.  Searching for polymorphisms that affect gene expression and mRNA processing: example ABCB1 (MDR1).

Authors:  Danxin Wang; Wolfgang Sadée
Journal:  AAPS J       Date:  2006-08-18       Impact factor: 4.009

9.  The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments.

Authors:  Katrin Offe; Sara E Dodson; James T Shoemaker; Jason J Fritz; Marla Gearing; Allan I Levey; James J Lah
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

10.  Molecular dissection of the interaction between amyloid precursor protein and its neuronal trafficking receptor SorLA/LR11.

Authors:  Olav M Andersen; Vanessa Schmidt; Robert Spoelgen; Jørgen Gliemann; Joachim Behlke; Denise Galatis; William J McKinstry; Michael W Parker; Colin L Masters; Bradley T Hyman; Roberto Cappai; Thomas E Willnow
Journal:  Biochemistry       Date:  2006-02-28       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.